Teva Capitalizes On Patent Expiry To Launch First Perforomist Rival

Analyst Projects Financial Hit For Originator Viatris

Teva
The Israeli giant has announced two US launches • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Generics

More from Products